| Literature DB >> 31148593 |
Nicola Bernabò1, Juliana Machado-Simoes2, Luca Valbonetti2, Marina Ramal-Sanchez2, Giulia Capacchietti2, Antonella Fontana3, Romina Zappacosta3, Paola Palestini4, Laura Botto4, Marco Marchisio5,6, Paola Lanuti5,6, Michele Ciulla3, Antonio Di Stefano3, Elena Fioroni7, Michele Spina7, Barbara Barboni2.
Abstract
Graphene Oxide (GO) is a widely used biomaterial with an amazing variety of applications in biology and medicine. Recently, we reported the ability of GO to improve the in vitro fertilization (IVF) outcomes in swine, a validated animal model with a high predictive value for human fertility. For that reason, here we characterized the mechanisms involved in this positive interaction by adopting an experimental approach combining biological methods (confocal microscopy analysis on single cell, flow cytometry on cell populations and co-incubation with epithelial oviductal cells), physical-chemical techniques (Differential Scanning Calorimetry and Thermogravimetric Analysis), and chemical methods (mass spectrometry and lipid measurement). As a result, we propose a model in which GO is able to extract cholesterol from the spermatozoa membrane without causing any detrimental effect. In this way, the cholesterol extraction promotes a change in membrane chemical-physical properties that could positively affect male gamete function, modulating sperm signalling function and increasing in this way the fertilizing potential, without losing the ability to physiologically interact with the female environment. In conclusion, these data seem to suggest new intriguing possibilities in engineering sperm membrane for improving assisted reproduction technologies outcomes, even in human medicine.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31148593 PMCID: PMC6544623 DOI: 10.1038/s41598-019-44702-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Lipidomic analysis of control (T0 and T2) and treated (different GO concentrations, BSA, MβCD) samples. Values expressed as percentage (mean). (Panel B) Values expressed as percentage (standard deviation; SD).
| Fatty Acids | T0 | T2 | H2O2 | BSA | MBCD | GO | GO | GO | GO | GO |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| C14:0 | 10,1 | 8,7 | 8,1 | 8,6 | 8,0 | 8,4 | 8,4 | 8,7 | 8,0 | 8,0 |
| Palmitic | 20,1 | 19,7 | 19,2 | 20,0 | 19,7 | 19,4 | 19,0 | 18,3 | 18,8 | 18,0 |
| Stearic | 10,0 | 9,7 | 10,0 | 10,1 | 10,6 | 9,8 | 10,2 | 9,5 | 10,2 | 10,2 |
| Oleic | 2,7 | 5,8 | 5,1 | 3,1 | 7,4 | 6,8 | 7,4 | 8,9 | 11,4 | 15,1 |
| Vaccenic | 1,7 | 1,5 | 1,5 | 1,5 | 1,4 | 1,5 | 1,4 | 1,4 | 1,4 | 1,3 |
| Cis-Linoleic | 2,2 | 2,1 | 2,1 | 2,4 | 2,0 | 2,1 | 2,0 | 1,8 | 2,1 | 1,8 |
| DGLA | 1,5 | 1,5 | 1,4 | 1,4 | 1,4 | 1,4 | 1,3 | 1,3 | 1,4 | 1,2 |
| AA | 3,0 | 2,6 | 2,9 | 2,9 | 2,7 | 2,8 | 2,7 | 2,8 | 2,7 | 2,5 |
| C22:4 n-6 | 1,1 | 1,1 | 1,1 | 1,2 | 1,2 | 1,1 | 1,1 | 1,1 | 1,0 | 1,0 |
| C22:5 n-6 | 24,5 | 24,4 | 24,9 | 25,2 | 23,6 | 24,2 | 23,9 | 23,8 | 22,1 | 21,1 |
| DHA | 23,1 | 22,7 | 23,5 | 23,6 | 22,1 | 22,6 | 22,5 | 22,6 | 20,8 | 19,8 |
| SFA | 40,2 | 38,1 | 37,3 | 38,8 | 38,3 | 37,6 | 37,6 | 36,4 | 37,0 | 36,1 |
| MUFA | 4,4 | 7,4 | 6,7 | 4,6 | 8,8 | 8,3 | 8,8 | 10,3 | 12,9 | 16,4 |
| PUFA | 55,4 | 54,5 | 56,1 | 56,6 | 53,0 | 54,1 | 53,6 | 53,3 | 50,1 | 47,4 |
| SFA/MUFA | 9,2 | 5,2 | 5,6 | 8,5 | 4,4 | 4,6 | 4,3 | 3,6 | 2,9 | 2,2 |
| OMEGA-6/OMEGA-3 | 1,4 | 1,4 | 1,4 | 1,4 | 1,4 | 1,4 | 1,4 | 1,4 | 1,4 | 1,4 |
| Peroxidation Index | 353,7 | 348,5 | 359,0 | 361,4 | 338,9 | 346,3 | 343,8 | 343,4 | 319,4 | 303,4 |
| Insaturation index | 235,5 | 235,0 | 241,1 | 240,6 | 230,1 | 234,4 | 233,2 | 234,2 | 221,5 | 214,5 |
Lipidomic analysis of control (T0 and T2) and treated (different GO concentrations, BSA, MβCD) samples. Values expressed as standard deviation.
| Fatty Acids | T0 | T2 | H2O2 | BSA | MBCD | GO | GO | GO | GO | GO |
|---|---|---|---|---|---|---|---|---|---|---|
| C14:0 | 0.351 | 1.113 | 0.798 | 1.408 | 0.996 | 1.431 | 1.299 | 1.542 | 1.000 | 1.099 |
| Palmitic (C16:0) | 0.728 | 3.219 | 0.385 | 1.066 | 0.895 | 0.730 | 1.103 | 0.235 | 1.631 | 1.452 |
| Stearic (C18:0) | 0.979 | 2.760 | 1.228 | 1.430 | 0.650 | 0.992 | 0.837 | 0.593 | 0.863 | 0.876 |
| Oleic (C18:1 n-9) | 0.155 | 0.925 | 0.779 | 0.229 | 0.785 | 0.486 | 1.069 | 1.099 | 1.617 | 2.391 |
| Vaccenic (C18:1) n-7 | 0.180 | 0.103 | 0.042 | 0.012 | 0.066 | 0.059 | 0.090 | 0.149 | 0.042 | 0.075 |
| Cis-Linoleic (C18:2 n-6) | 0.437 | 0.445 | 0.460 | 0.332 | 0.498 | 0.521 | 0.662 | 0.734 | 0.327 | 0.458 |
| DGLA (C20:3 n-6) | 0.289 | 0.297 | 0.131 | 0.102 | 0.153 | 0.169 | 0.229 | 0.263 | 0.173 | 0.184 |
| AA (C20:4 n-6) | 0.242 | 0.158 | 0.056 | 0.071 | 0.076 | 0.111 | 0.118 | 0.115 | 0.121 | 0.111 |
| C22:4 n-6 | 0.085 | 0.321 | 0.111 | 0.176 | 0.304 | 0.112 | 0.085 | 0.101 | 0.036 | 0.032 |
| C22:5 n-6 | 0.736 | 3.668 | 1.425 | 2.348 | 1.018 | 1.943 | 0.261 | 1.558 | 1.266 | 0.375 |
| DHA (C22:6 n-3) | 1.531 | 3.865 | 0.422 | 0.621 | 0.877 | 0.179 | 1.565 | 1.739 | 0.297 | 1.155 |
| SFA | 1.078 | 6.764 | 2.407 | 3.419 | 2.085 | 3.013 | 1.465 | 2.095 | 2.482 | 2.087 |
| MUFA | 0.100 | 0.984 | 0.760 | 0.217 | 0.813 | 0.512 | 1.056 | 1.094 | 1.595 | 2.349 |
| PUFA | 0.989 | 7.627 | 1.742 | 3.559 | 1.424 | 2.993 | 0.590 | 2.912 | 1.490 | 0.276 |
| SFA/MUFA | 0.452 | 0.465 | 0.921 | 0.602 | 0.652 | 0.489 | 0.664 | 0.314 | 0.570 | 0.487 |
| OMEGA-6/OMEGA-3 | 0.155 | 0.121 | 0.116 | 0.089 | 0.141 | 0.114 | 0.152 | 0.153 | 0.105 | 0.139 |
| Peroxidation Index | 10.0 | 53.1 | 6.6 | 20.2 | 5.9 | 14.7 | 10.2 | 19.1 | 6.2 | 5.9 |
| Insaturation index | 6.0 | 33.3 | 5.4 | 13.4 | 4.8 | 10.0 | 6.0 | 11.2 | 5.2 | 2.7 |
Figure 1Effect of GO exposure on sperm membrane lipid composition. (Panel A) Effect of the exposure (in term of lipid composition) of boar spermatozoa to different GO concentrations, BSA and MβCD, compared to the membrane composition in physiological conditions before (T0) and after 2 h of incubation under capacitating conditions (T2). (Panel B) PCA analysis realized by assessing the different experimental treatments studied (different GO concentrations, BSA, MβCD). (Panel C) Histogram showing the values of PC1 with reference to all the lipids measured. (Panel D) Histogram showing the values of PC2 with reference to all the lipids measured.
Figure 2Cholesterol/Phospholipids ratio in sperm samples. Data are refered to the different experimental treatments. The asterisks denote statistically different group of data.
Figure 3Differential Scanning Calorimetry (DSC) analysis. Different Tm corresponding to the sperm groups under study (treated with different GO concentrations, BSA or MβCD).
Melting temperatures (Tm) expressed in °C of the different samples are listed.
| Mean | Onset | Peak | End | Peak | ΔH (J/g) | Peak | Area |
|---|---|---|---|---|---|---|---|
| T0 | 31,8 | 34,9 | 46,0 | 14,2 | −11,8 | −1,0 | −46,1 |
| T2 | 35,2 | 38,0 | 47,8 | 12,6 | −26,3 | −1,1 | −56,5 |
| BSA | 34,3 | 37,9 | 53,2 | 18,9 | −33,8 | −1,5 | −104,6 |
| MβCD | 34,5 | 37,6 | 50,3 | 15,8 | −44,3 | −1,5 | −93,0 |
| GO 0,5 | 36,1 | 38,9 | 44,2 | 8,1 | −11,8 | −1,2 | −35,4 |
| GO 1 | 35,1 | 37,4 | 43,5 | 8,4 | −16,6 | −0,8 | −29,1 |
| GO 1.2 | 36,0 | 38,4 | 48,1 | 12,1 | −4,1 | −0,6 | −7,1 |
| GO 2.5 | 35,7 | 38,2 | 41,9 | 6,1 | −5,9 | −0,7 | −20,8 |
| GO 5 | 35,5 | 38,7 | 45,8 | 10,2 | −8,0 | −1,0 | −38,0 |
|
|
|
|
|
|
| |
| T0 | 1,6 | 1,3 | 5,5 | 6,9 | 4,1 | 0,5 | 10,0 |
| T2 | 4,5 | 4,5 | 6,1 | 6,4 | 42,5 | 0,7 | 55,3 |
| BSA | 2,9 | 2,6 | 7,4 | 8,8 | 30,0 | 0,5 | 70,0 |
| MβCD | 2,5 | 2,5 | 8,5 | 9,4 | 57,7 | 0,6 | 73,7 |
| GO 0,5 | 1,8 | 1,6 | 0,7 | 1,1 | 0,4 | 0,1 | 1,2 |
| GO 1 | 2,9 | 3,0 | 6,2 | 6,5 | 30,1 | 0,6 | 42,4 |
| GO 1.5 | 0,7 | 0,6 | 4,6 | 5,3 | 4,3 | 0,5 | 0,1 |
| GO 2.5 | 0,2 | 0,7 | 3,7 | 4,0 | 7,5 | 0,6 | 23,1 |
| GO 5 | 0,3 | 0,0 | 1,3 | 1,5 | 0,5 | 0,3 | 5,1 |
Figure 4Thermogravimetric Analysis (TGA). Thermogram shows the differences between the sperm samples treated with the different experimental treatments (different GO concentrations, BSA or MβCD).
Figure 5FRAP analysis of sperm cells. (Panel A) Exemplificative gallery showing the fluorescence recovery after photobleaching (FRAP) technique. (Panel B) Graph representing the values of Calculated Diffusion Coefficient (CDC), expressed as cm2/sec × 10−9, of sperm samples treated with the different experimental treatments (various GO concentrations, BSA or MβCD). The box plot represent the mean, 25°–75°, 5–90° percentile and out-layers. (Panel C) Dose-dependence linking GO concentration to Calculated Diffusion Coefficient (CDC).
Figure 6Flow cytometry results. (A) CTRL, BSA and MβCD samples at different times. Spermatozoa were stained with Fura 2-AM (x-axis) and Bis-oxonol (y-axis). (B) GO treated samples at different times. Spermatozoa were stained with Fura 2-AM (x-axis) and Bis-oxonol (y-axis).
Figure 7Confocal image showing the interaction of live spermatozoa with swine oviductal epithelial cells. Blue stain: Hoechst 33342 (nuclei); Red stain: DilC12 (membranes); Green stain CFDA (living spermatozoa).